scholarly journals Characterizing the Impact of Off-Axis Scan Acquisition on the Reproducibility of Total Retinal Thickness Measurements in SDOCT Volumes

2015 ◽  
Vol 4 (4) ◽  
pp. 3 ◽  
Author(s):  
Bhavna J. Antony ◽  
Paul F. Stetson ◽  
Michael D. Abramoff ◽  
Kyungmoo Lee ◽  
Johanna M. Colijn ◽  
...  
2011 ◽  
Vol 52 (9) ◽  
pp. 6925 ◽  
Author(s):  
Ilse Krebs ◽  
Eva Smretschnig ◽  
Sarah Moussa ◽  
Werner Brannath ◽  
Irene Womastek ◽  
...  

2018 ◽  
Vol 2018 ◽  
pp. 1-9 ◽  
Author(s):  
Edoardo Midena ◽  
Mark Gillies ◽  
Todd A. Katz ◽  
Carola Metzig ◽  
Chengxing Lu ◽  
...  

Purpose. To report the impact of baseline central retinal thickness (CRT) on outcomes in patients with diabetic macular edema (DME) in VIVID-DME and VISTA-DME. Methods. Post hoc analyses of two randomized controlled trials in which 862 DME patients were randomized 1 : 1 : 1 to treatment with intravitreal aflibercept 2.0 mg every 4 weeks (2q4), intravitreal aflibercept 2.0 mg every 8 weeks after five initial monthly doses (2q8), or macular laser photocoagulation at baseline and as needed. We compared visual and anatomical outcomes in subgroups of patients with baseline CRT < 400 μm and ≥400 μm. Results. At weeks 52 and 100, outcomes with intravitreal aflibercept 2q4 and 2q8 were superior to those in laser control-treated patients regardless of baseline CRT. When looked at in a binary fashion, the treatment effect of intravitreal aflibercept versus laser was not significantly better in the ≥400 μm than the <400 μm group; when looked at as a continuous variable, baseline CRT seemed to have an impact on the treatment effect of intravitreal aflibercept versus laser. Conclusions. Post hoc analyses of VIVID-DME and VISTA-DME demonstrated the benefits of intravitreal aflibercept treatment in DME patients with baseline CRT < 400 μm and ≥400 μm. This trial is registered with NCT01331681 and NCT01363440.


Nutrients ◽  
2020 ◽  
Vol 12 (4) ◽  
pp. 888
Author(s):  
Norihiro Nagai ◽  
Teru Asato ◽  
Sakiko Minami ◽  
Misa Suzuki ◽  
Hajime Shinoda ◽  
...  

Macular pigment (MP), which is composed of lutein/zeaxanthin/mezo-zeaxanthin, is concentrated in the central part of the retina, the macula. It protects the macula by absorbing short-wavelength light and suppressing oxidative stress. To evaluate whether MP levels are related to retinal neural protection and resulting health, we analyzed the association between the MP optical density (MPOD), and the macular thickness and volumes. Forty-three eyes of 43 healthy adult volunteers (21 men and 22 women; age: 22–48 (average 31.4 ± 1.1) years) were analyzed. Highly myopic eyes (<-6 diopters) were excluded. MPOD was measured using MPS2®, and the neural retinal thickness and volume were measured using optical coherence tomography. The mean MPOD was 0.589 ± 0.024, and it positively correlated with the central retinal thickness (P = 0.017, R = 0.360) and retinal volume of the fovea (1-mm diameter around the fovea; P = 0.029, R = 0.332), parafovea (1–3-mm diameter; P = 0.002, R = 0.458), and macula (6-mm diameter; P = 0.003, R = 0.447). In the macular area (diameter: 6 mm), MPOD was correlated with the retinal neural volume of the ganglion cell layer (P = 0.037, R = 0.320), inner plexiform layer (P = 0.029, R = 0.333), and outer nuclear layer (P = 0.020, R = 0.353). Thus, MPOD may help in estimating neural health. Further studies should determine the impact of MP levels on neuroprotection.


2017 ◽  
Vol 46 (0) ◽  
pp. 201-207
Author(s):  
Mio Sakate ◽  
Atsushi Fujiwara ◽  
Keisuke Kanenaga ◽  
Yasuhito Goto ◽  
Asuka Inagaki ◽  
...  

Eye ◽  
2015 ◽  
Vol 29 (8) ◽  
pp. 1111-1112
Author(s):  
K X Cheong ◽  
C S H Tan

Eye ◽  
2014 ◽  
Vol 28 (11) ◽  
pp. 1350-1354 ◽  
Author(s):  
G Pekel ◽  
F Akin ◽  
M S Ertürk ◽  
S Acer ◽  
R Yagci ◽  
...  

Ophthalmology ◽  
1997 ◽  
Vol 104 (4) ◽  
pp. 639-642 ◽  
Author(s):  
David Landau ◽  
Elad M. Schneidman ◽  
Tzah Jacobovitz ◽  
Yaacov Rozenman

2009 ◽  
Vol 93 (11) ◽  
pp. 1461-1467 ◽  
Author(s):  
P A Keane ◽  
P S Mand ◽  
S Liakopoulos ◽  
A C Walsh ◽  
S R Sadda

Sign in / Sign up

Export Citation Format

Share Document